44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pharmacology and Medicinal Chemistry

Sign up for email alert when new content gets added: Sign up

Pharmacological treatments for heart damage brought on by COVID-19

Author(s): Nicola Ward, Geoff Smith

The 2019 Coronavirus Illness (COVID-19), a current global pandemic that started in March 2020, is caused by SARS-CoV-2. About 935,000 people have died as a result of COVID-19 so far, across more than 200 nations. Injuries brought on by COVID-19 primarily impact the respiratory system, but they can also damage other organs, such as the cardiovascular system. The Angiotensin 2 Conversion Enzyme allows SARS-CoV-2 to enter host cells (ACE-2). ACE-2 is expressed in various organs, including the cardiovascular system, in addition to the lungs. A significant number of individuals with severe COVID-19 have cardiac abnormalities, such as myocardial fibrosis, edema, and pericarditis, according to several studies. Myocardial fibrotic lesions are brought on by the pathological remodeling of the extracellular matrix brought on by viral infection.


PDF
 
Google Scholar citation report
Citations : 19

Journal of Pharmacology and Medicinal Chemistry received 19 citations as per Google Scholar report

pulsus-health-tech
Top